🇺🇸 FDA

Intelligence Platform

Patents

Browse 763 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8247399

Photoactive metal nitrosyls for blood pressure regulation and cancer therapy

The Regents of the University of California · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8202242

Method of using vasoconstrictive agents during energy-based tissue therapy

Covidien LP · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8173615

TRPM-2 antisense therapy

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8153620

Photoactive metal nitrosyls for blood pressure regulation and cancer therapy

The Regents of the University of California · Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8153426

Preparation of antigen-presenting human gamma-delta T cells and use in immunotherapy

University College Cardiff Consultants Limited · Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8153136

Yeast-based vaccines as immunotherapy

The Regents of the University of Colorado · Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8148352

Antimicrobial therapy for bacterial infections

The Regents of the University of California · Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8147805

Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applica

The Board of Regents of the University of Texas System · Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8143232

Gene fusion targeted therapy

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8062643

Use of neurotoxin therapy for treatment of urologic and related disorders

The Regents of the University of Colorado · Granted Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8057807

Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

The Regents of the University of Colorado, a Body Corporate · Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8034334

Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8017135

Lipid-drug conjugates for local therapy of eye diseases

The Regents of the University of California · Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8003622

Peptide biosynthesis and pain therapy

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7998736

Adoptive immunotherapy with enhanced T lymphocyte survival

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7968511

Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7939635

Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919484

Combination therapy

Xenon Pharmaceuticals Inc. · Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919079

Cancer immunotherapy compositions and methods of use

The Regents of the University of California · Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7871775

Compositions and methods for the identification, assessment, prevention and therapy of hum

The Board of Regents of the University of Texas System · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7825231

Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain thera

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7815921

Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and

Ludwig-Maximilians-Universitat Munchen · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7807179

Modified reoviral therapy

The Board of Regents of the University of Texas System · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7799518

Nucleic acid molecules and proteins for the identification, assessment, prevention, and th

The Board of Regents of the University of Texas System · Granted Tue Sep 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted